ADMA Biologics Inc (ADMA) Q1 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good afternoon and welcome to the ADMA Biologics First Quarter twenty twenty six Financial Results and Business Update Conference Call on Wednesday, 05/06/2026. At this time, all participants are in a listen only mode. There will be a question and answer session to follow. Please be advised that this call is being recorded at the company's request and will be available on the company's website approximately two hours following the end of the call. At this time, I'd like to introduce the company. Please go ahead. Welcome everyone, and thank you for joining us this afternoon to discuss ADMA Biologics' financial results for the first quarter of twenty twenty six and recent corporate updates. I'm joined today by Adam Grossman, our President and Chief Executive Officer Terry Kohler, Chief Financial Officer and Treasurer. During today's call, Adam will provide some introductory comments and provide an update on corporate progress, and Terry will provide an overview of the company's first quarter twenty twenty six financial results. Finally, Adam will then provide some brief summary remarks before opening the call up for questions. Earlier today, we issued a press release detailing the first quarter twenty twenty six financial results and summarize certain achievements and recent corporate updates. The release is available on our website at www.admabiologics.com. Before we begin our formal comments, I'll remind you that we will be making forward looking assertions during today's call that represent the company's intentions, expectations or beliefs concerning future events, which constitute forward looking statements for the purposes of the Safe Harbor provisions under the Private Securities Litigation Reform Act of 1995. All forward looking statements are subject to factors...